These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 17621735)

  • 1. A survey study on diabetes management and complication status in primary care setting in Thailand.
    Nitiyanant W; Chetthakul T; Sang-A-kad P; Therakiatkumjorn C; Kunsuikmengrai K; Yeo JP
    J Med Assoc Thai; 2007 Jan; 90(1):65-71. PubMed ID: 17621735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control and complications of diabetes in urban primary care units in Thailand: a cross-sectional study.
    Puangpet T; Pongkunakorn T; Chulkarat N; Bunlangjit C; Surawit A; Pinsawas B; Mongkolsucharitkul P; Mayurasakorn K
    BMC Prim Care; 2022 Aug; 23(1):212. PubMed ID: 35996081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thailand diabetes registry project: prevalence of diabetic retinopathy and associated factors in type 2 diabetes mellitus.
    Chetthakul T; Deerochanawong C; Suwanwalaikorn S; Kosachunhanun N; Ngarmukos C; Rawdaree P; Krittiyawong S; Leelawatana R; Bunnag P; Plengvidhya N; Pratipanawatr T; Benjasuratwong Y; Mongkolsomlit S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 1():S27-36. PubMed ID: 17715831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meeting American Diabetes Association guidelines in endocrinologist practice.
    Miller CD; Phillips LS; Tate MK; Porwoll JM; Rossman SD; Cronmiller N; Gebhart SS
    Diabetes Care; 2000 Apr; 23(4):444-8. PubMed ID: 10857932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Thai DMS Diabetes Complications (DD.Comp.) project: prevalence and risk factors of diabetic retinopathy in Thai patients with type 2 diabetes mellitus.
    Jongsareejit A; Potisat S; Krairittichai U; Sattaputh C; Arunratanachote W
    J Med Assoc Thai; 2013 Nov; 96(11):1476-82. PubMed ID: 24428098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic control and chronic complications during a 3-year follow-up period in a cohort of type 2 diabetic patients attended in primary care in the Community of Madrid (Spain).
    Arrieta F; Piñera M; Iglesias P; Nogales P; Salinero-Fort MA; Abanades JC; Botella-Carretero JI; Calañas A; Balsa JA; Zamarrón I; Rovira A; Vázquez C;
    Endocrinol Nutr; 2014 Jan; 61(1):11-7. PubMed ID: 24182687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing optimal diabetes care and clinical outcomes in Thai patients with type 2 diabetes mellitus: a multilevel modelling analysis.
    Surawit A; Pongkunakorn T; Manosan T; Mongkolsucharitkul P; Chamnan P; Suvarnabhumi K; Puangpet T; Suta S; Pumeiam S; Pinsawas B; Ophakas S; Pisitpornsuk S; Utchin C; Mayurasakorn K
    BMJ Open; 2024 May; 14(5):e079415. PubMed ID: 38702083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic thresholds for diabetes: the association of retinopathy and albuminuria with glycaemia.
    Tapp RJ; Zimmet PZ; Harper CA; de Courten MP; McCarty DJ; Balkau B; Taylor HR; Welborn TA; Shaw JE;
    Diabetes Res Clin Pract; 2006 Sep; 73(3):315-21. PubMed ID: 16644057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence, drug treatment and metabolic control of diabetes mellitus in primary care].
    Pittrow D; Stalla GK; Zeiher AM; Silber S; März W; Pieper L; Klotsche J; Glaesmer H; Ruf G; Schneider HJ; Lehnert H; Böhler S; Koch U; Wittchen HU
    Med Klin (Munich); 2006 Aug; 101(8):635-44. PubMed ID: 16896570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cluster-randomized trial to estimate the effect of mobile screening and treatment feedback on HbA1c and diabetes-related complications in Tshwane primary health care clinics, South Africa.
    Webb EM; Rheeder P
    Prim Care Diabetes; 2017 Dec; 11(6):546-554. PubMed ID: 28690088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes diagnostic thresholds of the glycated hemoglobin A1c and fasting plasma glucose levels considering the 5-year incidence of retinopathy.
    Nakagami T; Takahashi K; Suto C; Oya J; Tanaka Y; Kurita M; Isago C; Hasegawa Y; Ito A; Uchigata Y
    Diabetes Res Clin Pract; 2017 Feb; 124():20-29. PubMed ID: 28081449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling incremental benefits on complications rates when targeting lower HbA
    Mostafa SA; Coleman RL; Agbaje OF; Gray AM; Holman RR; Bethel MA
    Diabet Med; 2018 Jan; 35(1):72-77. PubMed ID: 29057545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thailand diabetes registry project: prevalence of diabetic retinopathy and associated factors in type 1 diabetes mellitus.
    Chetthakul T; Likitmaskul S; Plengvidhya N; Suwanwalaikorn S; Kosachunhanun N; Deerochanawong C; Krittiyawong S; Leelawatana R; Benjasuratwong Y; Bunnag P; Prathipanawatr T; Ngarmukos C; Mongkolsomlit S; Rawdaree P
    J Med Assoc Thai; 2006 Aug; 89 Suppl 1():S17-26. PubMed ID: 17715830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 2 diabetic patient-centered care.
    Prueksaritanond S; Tubtimtes S; Asavanich K; Tiewtranon V
    J Med Assoc Thai; 2004 Apr; 87(4):345-52. PubMed ID: 15217167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes care and complications in primary care in the Tshwane district of South Africa.
    Webb EM; Rheeder P; Van Zyl DG
    Prim Care Diabetes; 2015 Apr; 9(2):147-54. PubMed ID: 24933340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Value of Fasting Glucose, Postload Glucose, and Hemoglobin A
    Lu J; He J; Li M; Tang X; Hu R; Shi L; Su Q; Peng K; Xu M; Xu Y; Chen Y; Yu X; Yan L; Wang T; Zhao Z; Qin G; Wan Q; Chen G; Dai M; Zhang D; Gao Z; Wang G; Shen F; Luo Z; Qin Y; Chen L; Huo Y; Li Q; Ye Z; Zhang Y; Du R; Cheng D; Liu C; Wang Y; Wu S; Yang T; Deng H; Li D; Lai S; Bloomgarden ZT; Chen L; Zhao J; Mu Y; Ning G; Wang W; Bi Y;
    Diabetes Care; 2019 Aug; 42(8):1539-1548. PubMed ID: 31152120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recurrence and influencing factors of diabetic foot ulcer in patients with type 2 diabetes mellitus].
    Shen JF; Jiang RM; Wang ZQ; Li M; Li J; Xie SY; Kang JJ
    Zhonghua Shao Shang Za Zhi; 2020 Oct; 36(10):947-952. PubMed ID: 33105947
    [No Abstract]   [Full Text] [Related]  

  • 18. Prediction of type 2 diabetes mellitus using fasting plasma glucose and HbA1c levels among individuals with impaired fasting plasma glucose: a cross-sectional study in Thailand.
    Sitasuwan T; Lertwattanarak R
    BMJ Open; 2020 Nov; 10(11):e041269. PubMed ID: 33172945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of HbA1c in management of diabetes mellitus.
    Al-Ghamdi AA
    Saudi Med J; 2004 Mar; 25(3):342-5. PubMed ID: 15048173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DiabCare Asia--India Study: diabetes care in India--current status.
    Raheja BS; Kapur A; Bhoraskar A; Sathe SR; Jorgensen LN; Moorthi SR; Pendsey S; Sahay BK
    J Assoc Physicians India; 2001 Jul; 49():717-22. PubMed ID: 11573557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.